Otivio AS

📍 Oslo, Norway🗓 Founded 2010👥 9 employees💰 Last funded Aug 2025
Otivio AS is a medical device company founded in 2010 and based in Oslo, Norway. In 2021, subsidiaries were established in Denmark and Germany. Otivio’s CE-certified product, FlowOx™, is a novel and non-invasive medical device for hospital and home use. Applications include the treatment of peripheral arterial disease (PAD) related problems such as pain, reduced walking distance and chronic ulcers. The therapeutic value of FlowOx has been proven in numerous clinical and observational studies. Early patient data suggests that FlowOx may also be able to alleviate Multiple Sclerosis (MS) symptoms. The use of FlowOx™ is comfortable and easy: the system generates an intermittent negative pressure (INP) that stimulates the blood circulation in the lower legs and feet, thus improving the blood flow and oxygen supply. The company is looking for partners for commercial development. Contact Otivio at info@otivio.com for more information.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2010
Founded
Investor geography2 countries
United Kingdom
1
Norway
1
Frequently asked questions
Who invested in Otivio AS?
Otivio AS has 2 investors on record on gritt.io.
When did Otivio AS last raise funding?
The most recent investment in Otivio AS recorded on gritt.io was in August 2025.
When was Otivio AS founded?
Otivio AS was founded in 2010.
What industry is Otivio AS in?
Otivio AS operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Otivio AS based?
Otivio AS is headquartered in Oslo, Norway.